Non-invasive cardiovascular examination

Non-invasive cardiac function testing, also known as non-invasive cardiac hemodynamics, is an advanced technology for cardiovascular management. It accurately assesses a patient's hemodynamic status without requiring invasive procedures, effectively improving the early diagnosis rate of cardiovascular disease and enabling early detection, diagnosis, and treatment of the disease, further reducing the incidence and mortality of cardiovascular disease.

Technology maturity

The non-invasive smart cardiac function screening system has been certified by the US FDA and registered as a Class II, Grade B medical device in China. It is suitable for use in non-medical environments and has no special requirements. (Including hardware and software)

FDA Records

TEBCO (Hardware)

(Thoracic Electrical Bioimpedance Cardiac Output)

Class II, DXG

K962128

HOTMAN (Software)

(Hemodynamic Oxygen Transport MANagement) System

K952172

Class II, DSB

Policy and medical insurance support

The National Health Commission actively promotes cardiovascular disease prevention and treatment, and has issued a series of health documents:

Healthy China 2030 Planning Outline: A health and wellness work policy centered on people's health and focusing on the grassroots, aimed at improving people's health and promoting the construction of a healthy China.

"Several Opinions on Further Strengthening Basic Public Health Services": Further strengthen basic public health services.

Specific measures include improving service offerings, strengthening service capacity building, and improving service efficiency. "Notice on the 2024 Basic Public Health Service Plan": Related matters will continue to expand coverage for beneficiary groups, including the elderly, those with hypertension, and chronic diseases such as type 2 diabetes.

The economic burden of cardiovascular disease and the prevention gap

Government spending pressure: The waiting time for angioplasty surgery in public hospitals is as long as 86-96 weeks. Some patients develop critical illness due to delayed treatment, significantly increasing treatment costs.

There is an urgent need for grassroots screening:

If patients develop severe conditions (such as heart failure) due to delayed treatment, they will need long-term hospitalization or bypass surgery, which is much more expensive than early intervention. The cost of late-stage coronary heart disease surgery (such as bypass surgery) can reach hundreds of thousands of Hong Kong dollars, and is accompanied by loss of income and the burden of family care.
Cardiovascular disease has long been the third leading cause of death in Hong Kong. Nearly 60% of people aged 65 and above suffer from high blood pressure or high cholesterol, significantly increasing the demand for medical care.
The Hospital Authority estimates that every HK$1 invested in early screening in the community can save HK$8 in late-stage treatment costs (such as reduced emergency room use and late-stage surgery).
At the 2025 Hospital Authority Symposium, Chief Executive Dr. Ko Pat-shing stated, "Digital transformation and community-based prevention integration are key to sustainable healthcare. For every $1 saved in acute care resources through grassroots screening, $8 in terminal care budgets can be freed up." This statement was based on the Hospital Authority's internal analysis of operational data from chest pain and stroke centers (for example, the Chest Pain Center at Queen Mary Hospital reduced acute myocardial infarction surgeries by 20% through early intervention). Interim reports from the Chronic Disease Co-management Program showed a 32% reduction in subsequent hospitalizations for elderly individuals who participated in screening for the three highs, indirectly validating the cost-saving model.

Core Competitive Advantages

1. Build a universal preventive medical network and empower primary care

We are committed to building a nationwide non-invasive cardiovascular technology service network, effectively filling the gap in primary care diagnostic resources. By establishing a comprehensive cardiovascular defense system encompassing "screening-prevention-intervention," we are establishing a universal preventive healthcare network. This has tripled the early detection rate of cardiovascular disease and significantly reduced the incidence of severe cases by over 40% (industry data reference). This has helped improve cardiovascular health for all and fulfilled our mission of universal healthcare access.

2. Deepen the integration of medical insurance and inclusive healthcare to improve access to healthcare

Deeply integrated with the national medical insurance payment system, we have innovatively created a model for integrated and inclusive healthcare. This has successfully reduced the per capita cost of cutting-edge medical technology by 60-80%, achieving a medical insurance reimbursement rate of 85-90%, and effectively addressing the industry's unaffordable access to high-tech medical care. By opening up medical insurance payment channels, advanced medical technologies can be brought to every household at affordable prices, achieving universal access to primary healthcare services and promoting the equitable distribution and efficient use of medical resources.

3. Improve the closed loop of clinical research translation to ensure sustainable development

We have established a demand-driven R&D system, developing technical solutions closely centered around clinical pain points. This creates a complete closed-loop system from clinical problem discovery to technology development and rapid transition to mass production, enabling efficient transition to mass production within 12-18 months. This clinically driven R&D model not only ensures the practicality and market value of our technologies, but also ensures the sustainability of our technological innovation, enabling us to continue to deepen our presence in the medical technology arena and maintain a long-term competitive advantage.

Amazing market profit potential

1. Medical insurance drives traffic: With the advantage of medical insurance reimbursement, it can quickly attract a large number of patients and reduce promotion costs.

2. Significant compound interest effect: As the checkpoint network expands, revenue grows exponentially, and the return on investment is extremely promising.